|
|
Nabi Biopharmaceuticals - Company Profile Snapshot
| Company Profile: |
Nabi Biopharmaceuticals |
| Ticker: |
NABI |
| Exchanges: |
NAS |
| 2007 Sales: |
n/a |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
52 |
Business Description
Nabi Biopharmaceuticals. The Group's principal activities are to discover, develop, manufacture and market vaccines and antibody based biopharmaceutical products. The Group operates in two segments: Biopharmaceutical products and Antibody products. The Biopharmaceutical products segment includes the production and sale of proprietary biopharmaceutical products, as well as research and development efforts for the biopharmaceutical product line. The Antibody products segment includes the collection and sale of non-specific and specialty antibody products to other biopharmaceutical manufacturers, as well as the production and sale of antibody-body control and diagnostic products and laboratory testing services. The Group operates in the United States, South Korea, Israel and Canada.
|
Not the Report you are looking for? Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
